SECOND SIGHT MEDICAL PRODUCT (EYES)

US81362J3086 - Common Stock

4.14  -0.22 (-5.05%)

After market: 4.0921 -0.05 (-1.16%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.003.38M6.90M
Cost Of Goods
-130.00K-130.00K-500.00K2.15M4.89M
Gross Profit
130.00K130.00K500.00K1.23M2.01M
Operating Expenses
9.27M9.06M13.17M31.82M36.63M
Research and Development
2.83M2.37M4.84M13.14M10.01M
Selling, General, and Administrative Expenses
6.44M6.69M8.33M18.68M26.63M
Operating Income
-9.14M-8.93M-12.67M-30.60M-34.63M
Interest Income/Expense
67.00K12.00K16.00K362.00K86.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/A0.00-2.23M-3.36M-555.00K
Income Before Taxes
-9.07M-8.92M-14.88M-33.59M-35.09M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-9.07M-8.92M-14.88M-33.59M-35.09M
EBITDA
-9.08M-8.86M-12.50M-30.20M-34.19M
 
Per Share Data
EPS Diluted Total Ops
-0.69-0.82-2.17-6.85-12.69
Non GAAP EPS
N/AN/A-0.85-6.54N/A
 
Statistics
Gross Profit Margin
N/AN/AN/A36.31%29.12%
Profit Margin
N/AN/AN/A-994.14%-508.90%
Operating Profit Margin
N/AN/AN/A-905.50%-502.10%

All data in USD

Charts